Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Bezborodova Oa"'
Autor:
Bezborodova OA; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia. Electronic address: olgabezborodova@yandex.ru., Pankratov AA; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia., Kogan BY; Organic Intermediates and Dyes Institute, B. Sadovaya 1/4, Moscow 123995, Russia,. Electronic address: bkogan@mail.mipt.ru., Nemtsova ER; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia. Electronic address: nemtz@yandex.ru., Venediktova JB; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia. Electronic address: uluaz@yandex.ru., Karmakova TA; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia. Electronic address: kalmar123@yandex.ru., Butenin AV; Organic Intermediates and Dyes Institute, B. Sadovaya 1/4, Moscow 123995, Russia,. Electronic address: abutenin@yandex.ru., Feizulova RK; Organic Intermediates and Dyes Institute, B. Sadovaya 1/4, Moscow 123995, Russia,. Electronic address: rfeizulova@yandex.ru., Khokhlova VA; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia. Electronic address: nostocus@yandex.ru., Obraztsova EA; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya 16/10, Moscow 117997, Russia. Electronic address: aobraztsova@yandex.ru., Kaprin AD; Moscow Hertzen Research Institute of Oncology- branch of National Medical Radiology Research Center, Ministry of Health of the Russian Federation, 2(nd) Botkinsky Passage 3, Moscow 125284, Russia. Electronic address: kaprin@mail.ru.
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2024 Jun 28; Vol. 61, pp. 102768. Date of Electronic Publication: 2024 Jun 28.
Autor:
Rakitina OA; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Kuzmich AI; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Bezborodova OA; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Kondratieva SA; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Pleshkan VV; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Zinovyeva MV; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Didych DA; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Sass AV; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Snezhkov EV; Laboratory of Human Gene Structure and Functions, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Kostina MB; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Koksharov MO; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.; Stagen LLC, Moscow, Russia., Alekseenko IV; Group of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.; Stagen LLC, Moscow, Russia.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 26; Vol. 15, pp. 1410564. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).
Autor:
Shestovskaya MV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia. Electronic address: MShestovskaya@cspfmba.ru., Luss AL; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia., Bezborodova OA; P. Hertsen Moscow Oncology Research Institute - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinskiy p. 3, Moscow 125284, Russia., Kulikov PP; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia., Antufrieva DA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia., Plotnikova EA; P. Hertsen Moscow Oncology Research Institute - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinskiy p. 3, Moscow 125284, Russia., Makarov VV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia., Yudin VS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia., Pankratov AA; P. Hertsen Moscow Oncology Research Institute - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinskiy p. 3, Moscow 125284, Russia., Keskinov AA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Pogodinskaya st. 10/1, Moscow 119435, Russia.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jun; Vol. 175, pp. 116668. Date of Electronic Publication: 2024 May 02.
Autor:
Shestovskaya MV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Schukinskaya st. 5/1, Moscow 119435, Russia., Luss AL; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Schukinskaya st. 5/1, Moscow 119435, Russia.; The Department of Technology of Chemical, Pharmaceutical and Cosmetic Products Mendeleev of University of Chemical Technology of Russia, Miusskaya sq. 9, Moscow 125047, Russia., Bezborodova OA; P. Hertsen Moscow Oncology Research Institute of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinskiy p. 3, Moscow 125284, Russia., Makarov VV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Schukinskaya st. 5/1, Moscow 119435, Russia., Keskinov AA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Schukinskaya st. 5/1, Moscow 119435, Russia.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2023 Sep 30; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 30.
Autor:
Leontyev DS; Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia. danila.leontyev@gmail.com., Glazkova DV; Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia., Bezborodova OA; P. A. Hertsen Moscow Oncology Research Institute - Affiliated Branch of National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia., Tsyganova GM; Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia., Urusov FA; Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia.; N. F. Izmerov Research Institute of Occupational Health, Moscow, Russia., Pankratov AA; P. A. Hertsen Moscow Oncology Research Institute - Affiliated Branch of National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia., Shipulin GA; Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia., Bogoslovskaya EV; Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical-Biological Agency of Russia, Moscow, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2023 May; Vol. 175 (1), pp. 63-66. Date of Electronic Publication: 2023 Jun 20.
Autor:
Glazkova DV; Center for Strategic Planning and Management of Medical and Biological Health Risks, Federal Medical-Biological Agency of the Russian Federation, Moscow, 119992 Russia., Bogoslovskaya EV; Center for Strategic Planning and Management of Medical and Biological Health Risks, Federal Medical-Biological Agency of the Russian Federation, Moscow, 119992 Russia., Urusov FA; Center for Strategic Planning and Management of Medical and Biological Health Risks, Federal Medical-Biological Agency of the Russian Federation, Moscow, 119992 Russia.; Izmerov Research Institute of Occupational Health, Moscow, 105275 Russia.; flanger.fx@mail.ru., Kartashova NP; Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064 Russia., Glubokova EA; Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064 Russia., Gracheva AV; Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064 Russia., Faizuloev EB; Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064 Russia., Trunova GV; National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, 125284 Russia., Khokhlova VA; National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, 125284 Russia., Bezborodova OA; National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, 125284 Russia., Pankratov AA; National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, 125284 Russia., Leneva IA; Mechnikov Research Institute of Vaccines and Sera, Moscow, 105064 Russia., Shipulin GA; Center for Strategic Planning and Management of Medical and Biological Health Risks, Federal Medical-Biological Agency of the Russian Federation, Moscow, 119992 Russia.
Publikováno v:
Molekuliarnaia biologiia [Mol Biol (Mosk)] 2022 Sep-Oct; Vol. 56 (5), pp. 774-782.
Autor:
Chistyakov DV; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia., Guryleva MV; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 119234 Moscow, Russia., Stepanova ES; Peoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Street, 117198 Moscow, Russia., Makarenkova LM; Peoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Street, 117198 Moscow, Russia., Ptitsyna EV; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 119234 Moscow, Russia., Goriainov SV; Peoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Street, 117198 Moscow, Russia., Nikolskaya AI; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 119234 Moscow, Russia., Astakhova AA; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia., Klimenko AS; Peoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Street, 117198 Moscow, Russia., Bezborodova OA; National Medical Radiology Research Center, P. Hertsen Research Institute of Oncology, 125284 Moscow, Russia., Rasskazova EA; National Medical Radiology Research Center, P. Hertsen Research Institute of Oncology, 125284 Moscow, Russia., Potanina OG; Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia., Abramovich RA; Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia., Nemtsova ER; National Medical Radiology Research Center, P. Hertsen Research Institute of Oncology, 125284 Moscow, Russia., Sergeeva MG; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Apr 18; Vol. 14 (8). Date of Electronic Publication: 2022 Apr 18.
Autor:
Maxim M. Shmarov, I. L. Tutykhina, Raisa I. Yakubovskaya, V. I. Chissov, D. Yu. Logunov, B. S. Naroditskii, Alexander L. Gintsburg, Bezborodova Oa, E. R. Nemtsova
Publikováno v:
Molecular Genetics, Microbiology and Virology. 25:77-83
A recombinant pseudoadenovirus nanostructure (RPAN) based on human adenovirus of the 5th serotype that carries the human Lf gene was constructed to develop an effective system of human lactoferrin (Lf) production. It was shown using the model of toxi
Autor:
E. R. Nemtsova, A. L. Ginzburg, I. L. Tutykhina, Raisa I. Yakubovskaya, D. Yu. Logunov, Maxim M. Shmarov, L. V. Verkhovskaya, B. S. Naroditskii, Bezborodova Oa
Publikováno v:
Molecular Genetics, Microbiology and Virology. 24:32-36
The method of homologous recombination in E. coli cells was used to obtain a pseudoadenovirus nanostructure Ad5-lf that ensures the effective expression of the lactoferrin (Lf) gene in a permissive cell system with the high production of recombinant
Autor:
Nemtsova ER; P. A. Hertsen Moscow Oncology Research Institute - Branch of National Medical Research Center of Radiology, Ministry of Health of the Russian Federation, Moscow, Russia. nemtz@yandex.ru., Tikhonova EG; V. N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia., Bezborodova OA; P. A. Hertsen Moscow Oncology Research Institute - Branch of National Medical Research Center of Radiology, Ministry of Health of the Russian Federation, Moscow, Russia., Pankratov AA; P. A. Hertsen Moscow Oncology Research Institute - Branch of National Medical Research Center of Radiology, Ministry of Health of the Russian Federation, Moscow, Russia., Venediktova JB; P. A. Hertsen Moscow Oncology Research Institute - Branch of National Medical Research Center of Radiology, Ministry of Health of the Russian Federation, Moscow, Russia., Korotkevich EI; V. N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia., Kostryukova LV; V. N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia., Tereshkina JA; V. N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2020 Oct; Vol. 169 (6), pp. 778-782. Date of Electronic Publication: 2020 Oct 24.